MALABSORPTION OF PYRIDOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS

被引:19
作者
COHAN, SL
DRETCHEN, KL
NEAL, A
机构
[1] GEORGETOWN UNIV,SCH MED,DEPT NEUROL,WASHINGTON,DC 20007
[2] GEORGETOWN UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC 20007
关键词
D O I
10.1212/WNL.27.3.299
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:299 / 301
页数:3
相关论文
共 14 条
[1]  
BERTALANFFY FD, 1962, GASTROENTEROLOGY, V43, P472
[2]   INFLUENCE OF CHRONIC NEOSTIGMINE TREATMENT ON NUMBER OF ACETYLCHOLINE RECEPTORS AND RELEASE OF ACETYLCHOLINE FROM RAT DIAPHRAGM [J].
CHANG, CC ;
CHEN, TF ;
CHUANG, ST .
JOURNAL OF PHYSIOLOGY-LONDON, 1973, 230 (03) :613-618
[3]   PHARMACOKINETICS OF PYRIDOSTIGMINE [J].
COHAN, SL ;
POHLMANN, JLW ;
MIKSZEWSKI, J ;
ODOHERTY, DS .
NEUROLOGY, 1976, 26 (06) :536-539
[4]  
COHAN SL, 1975, 5TH P M INT SOC NEUR, V439
[5]   STUDY OF LONG-TERM ANTICHOLINESTERASE THERAPY - EFFECTS ON NEUROMUSCULAR-TRANSMISSION AND ON MOTOR ENDPLATE FINE-STRUCTURE [J].
ENGEL, AG ;
LAMBERT, EH ;
SANTA, T .
NEUROLOGY, 1973, 23 (12) :1273-1281
[6]   MYASTHENIA GRAVIS - NEW HYPOTHESIS OF PATHOGENESIS AND A NEW FORM OF TREATMENT [J].
ENGEL, WK ;
WARMOLTS, JR .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 183 (NSEP) :72-+
[7]   NEUROMUSCULAR JUNCTION IN MYASTHENIA-GRAVIS - DECREASED ACETYLCHOLINE RECEPTORS [J].
FAMBROUGH, DM ;
DRACHMAN, DB ;
SATYAMURTI, S .
SCIENCE, 1973, 182 (4109) :293-295
[8]   PHARMACOLOGICAL CONSIDERATIONS IN THE TREATMENT OF MYASTHENIA GRAVIS [J].
GLASER, GH .
ADVANCES IN PHARMACOLOGY, 1963, 2 :113-160
[9]   CRISIS PRECRISIS AND DRUG RESISTANCE IN MYASTHENIA GRAVIS [J].
GLASER, GH .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1966, 135 (A1) :335-+
[10]   RENEWAL OF CELL POPULATIONS [J].
LEBLOND, CP ;
WALKER, BE .
PHYSIOLOGICAL REVIEWS, 1956, 36 (02) :255-276